In this video, Zeenat Safdar, MD, MS, a STELLAR trial investigator, discusses the STELLAR trial results, which supported the FDA approval of sotatercept. Sotatercept is the first activin signaling inhibitor...
The FDA has approved sotatercept-csrk, the first activin signaling inhibitor therapy, for the management of patients with pulmonary arterial hypertension (PAH). Based on the Phase 3 STELLAR trial,...
Based on findings from the Phase 3 A DUE study, Janssen Research & Development, LLC recently submitted a New Drug Application to the FDA seeking approval of an investigational once-daily, single-tablet...
Pulmonary arterial hypertension is rare, but which patient population is most likely to develop the disorder? See if you know the answer by taking our pop quiz.
Pulmonary hypertension (PH) affects the lungs and the heart. Do you think cardiologists alone or pulmonologists alone should manage patients with PH? Let us know by taking our poll.
In this “Test Your Knowledge” quiz series, Michael J. Bloch, MD, asks what is considered the most widely accepted definition of normal pulmonary arterial pressure.
In this “Test Your Knowledge” quiz series, Michael J. Bloch, MD, outlines a patient case of pulmonary arterial hypertension and asks you to classify the patient based on World Health Organization...
In this video, Zeenat Safdar, MD, MS, a STELLAR trial investigator, discusses the STELLAR trial results, which supported the FDA approval of sotatercept. Sotatercept is the first activin signaling inhibitor...
Based on findings from the Phase 3 A DUE study, Janssen Research & Development, LLC recently submitted a New Drug Application to the FDA seeking approval of an investigational once-daily, single-tablet...
In this podcast, Ryan Tedford, MD, answers our questions about his team's latest study, which assessed the impact of the new definition of pulmonary hypertension on heart transplant outcomes. Pulmonary...
In this podcast, Aaron Waxman, MD, PhD, discusses the role of exercise hemodynamics in the diagnosis and treatment of pulmonary hypertension and the types of exercise that are best for patients with...
05/29/2022
Critical Observations in Pulmonary Medicine, Ep. 3
Critical Observations in Pulmonary Medicine, Ep. 3
In this episode, Dr Rizzo interviews Paul M. Hassoun, MD, Johns Hopkins School of Medicine (Baltimore MD), about his research on Pulmonary Arterial Hypertension (PAH), including its pathogenesis, the...
